What are systemic antifungals, really?
Systemic antifungals are drugs that fight a fungal infection from the inside of your body rather than from a cream rubbed on the surface. The word "systemic" is the whole point: the drug travels through your bloodstream and reaches places a topical product never could — a nail bed, the lungs, the bloodstream itself, the lining of the brain. They exist because fungi are not bacteria and not viruses. A fungus is a more complicated organism, closer to one of your own cells than a germ has any right to be, and that family resemblance is the central problem of this entire drug class. Anything you throw at the fungus risks hitting you too.
The family splits into a few main branches. The azoles are the workhorses you have probably met — fluconazole (Diflucan), itraconazole (Sporanox), voriconazole (Vfend), posaconazole (Noxafil). Then there is terbinafine (Lamisil), the allylamine famous for nail infections. The echinocandins — caspofungin (Cancidas), micafungin (Mycamine), anidulafungin (Eraxis) — are hospital drugs given by drip. And the old heavyweight, amphotericin B (AmBisome is the modern liposomal version), a polyene reserved for the most dangerous infections. Different chemistry, different jobs, but most of them are aiming at the same handful of weak spots.
How they work — the simple version
Picture a fungal cell as a tiny fortress with two protective layers: an inner skin called the cell membrane and an outer wall built around it. The whole class of antifungals is, essentially, a set of ways to sabotage construction.
Your own cells stiffen their membranes with cholesterol. A fungus uses a slightly different molecule for the same job — ergosterol. Think of ergosterol as the fungus's signature building material, the rivets that hold its skin together and keep it watertight. Human cells do not make it. That difference is the loophole every azole and the allylamine exploit.
Azoles cut off the supply of ergosterol. They jam a specific enzyme on the production line (lanosterol 14-alpha-demethylase, if you want the formal name), so the factory keeps running but the rivets never arrive. The cell keeps building membrane, but the membrane comes out leaky and full of holes. The fungus does not explode; it just slowly loses its ability to hold itself together and stops being able to grow. This is why azoles are described as fungistatic against many organisms — they halt the building work rather than demolishing what is already there. The biology of this pathway, and how fungi learn to dodge the drug, is laid out by Cowen and colleagues in Cold Spring Harbor Perspectives in Medicine (2014).
Terbinafine attacks the same supply chain, but earlier and more brutally. It blocks an enzyme called squalene epoxidase, near the very start of the line. Two things happen at once. The rivets still never get made — but on top of that, the raw ingredient that was waiting to be processed, a substance called squalene, has nowhere to go. It piles up inside the cell like deliveries stacking outside a closed warehouse, and at high enough levels squalene is toxic to the fungus itself. So terbinafine does not just starve the cell, it makes the cell poison itself. Norman Ryder mapped out this mechanism in the British Journal of Dermatology back in 1992.
Echinocandins ignore the membrane entirely and go after the outer wall. That wall is held together by a kind of cement called beta-1,3-glucan, and the echinocandins shut down the single factory that produces it. No cement, no wall, and the cell bursts under its own internal pressure. The beauty of this target is that human beings have no cell wall and no glucan at all — so there is almost nothing in your body for the drug to accidentally hit. That is the secret behind their unusually clean safety record.
Amphotericin B is the bluntest instrument. Instead of cutting off the ergosterol supply, it walks up to the ergosterol already sitting in the membrane and punches holes straight through it, so the cell's insides leak out. Effective and fast — but because the molecule has a little trouble telling fungal ergosterol from human cholesterol, it tends to bruise your own cells in the process.
What else they do to your body, beyond fighting fungus
Here is the rule that makes the side effects predictable: the more precisely a drug targets something only fungi have, the safer it is for you. The further it strays toward biology you share with the fungus, the more collateral damage it does.
The azoles and your liver's filing system. The biggest problem with azoles has nothing to do with fungus. The same kind of enzyme they block in the fungus belongs to a giant family of enzymes — the CYP450 system — and your liver uses its own version of that family to break down a huge fraction of all medicines. Azoles gum up that machinery. The result is that other drugs you take stop being cleared at the normal speed and start building up to higher levels than intended. Blood thinners, transplant drugs, cholesterol pills, sedatives — all can spike. Fluconazole combined with the blood thinner warfarin, for example, is a classic recipe for dangerous bleeding unless clotting is being watched closely. We come back to this in the next section, because it is the single most important thing about the whole class.
Liver injury itself. Itraconazole and voriconazole can also strain the liver directly, which is why people on a course often have their liver enzymes checked along the way. Terbinafine carries a rare but real risk of liver inflammation too.
The voriconazole light show. Voriconazole has a genuinely strange and almost charming side effect: many people get temporary visual disturbances, a sense that everything has brightened or that colours have shifted, sometimes flashes of light. It usually fades within an hour and disappears as treatment continues, but it is striking enough that patients are warned in advance so they do not panic. Over the long term voriconazole also makes skin far more sensitive to sunlight.
Terbinafine and the taste of nothing. Terbinafine's signature quirk is taste disturbance — food can go flat, metallic, or simply vanish in flavour for weeks. It is unsettling, usually reversible, and worth knowing about so you do not assume something worse is happening.
Amphotericin B and the kidneys. Amphotericin's hole-punching habit is hardest on the kidneys, which is why it earned the grim nickname "ampho-terrible." The liposomal version, AmBisome, was engineered specifically to smuggle the drug to the fungus while sparing the kidneys, keeping much of the punch with less of the damage.
Echinocandins, the quiet ones. Because their target simply does not exist in humans, echinocandins are the gentlest of the bunch and barely interfere with other drugs. That is precisely why they are the go-to choice for the sickest, most fragile patients, where one more drug interaction could be the tipping point.
If you have read our piece on NSAIDs, the logic will feel familiar: the side effects are not a separate list of warnings bolted on at the end — they are the direct shadow of how the drug works.
What people usually take with them, and why
Antifungal treatment is rarely a free-for-all. Which drug goes with which infection is spelled out in formal guidelines, and the combinations matter.
For invasive aspergillosis — a serious lung-and-beyond mould infection — voriconazole is the recommended first-line treatment, per the Infectious Diseases Society of America's 2016 aspergillosis guideline (Patterson et al.).
For candidemia, Candida in the bloodstream, the IDSA's 2016 candidiasis guideline (Pappas et al.) leans on echinocandins as the initial choice for critically ill or neutropenic patients — exactly because of that clean interaction profile — while fluconazole is reasonable for more stable patients whose strain is known to be susceptible.
For cryptococcal meningitis, a fungal infection of the brain lining most often seen in people with weakened immunity, the approach is a relay race. The IDSA's 2010 cryptococcal guideline (Perfect et al.) describes starting with amphotericin B paired with another drug, flucytosine, to hit the infection hard, then handing off to fluconazole to consolidate and maintain the win over the following weeks and months.
For nail fungus (onychomycosis) caused by the common dermatophyte moulds, terbinafine generally outperforms the azoles, a finding supported by Cochrane's review of the trial evidence (Bell-Syer et al.).
The interactions worth flagging — again, mostly an azole story:
- Azoles plus statins. Slowing statin breakdown can drive the cholesterol drug to levels that damage muscle, and some specific pairings are considered off-limits entirely.
- Azoles plus QT-prolonging drugs. Several azoles can stretch the heart's electrical cycle; stacking them with other drugs that do the same raises the risk of a dangerous rhythm.
- Azoles plus transplant or immune-suppressing drugs like cyclosporine and tacrolimus. The azole pushes these already-tricky drugs higher, edging them toward toxicity unless levels are tracked.
- Azoles plus rifampicin. This one runs backwards: the antibiotic rifampicin revs up the liver's clearance machinery and can drop azole levels so far that the antifungal essentially stops working.
This is the same theme that runs through our articles on antibiotics and antiepileptics: a drug that lives in the liver's metabolism is a drug that talks to everything else you take.
Red flags — when to call a doctor
These are the moments to stop waiting and get medical advice, not to tough it out until the next appointment.
- Yellowing of the skin or the whites of the eyes, pain under the right ribs, or dark urine while taking itraconazole, voriconazole or terbinafine. That combination points at the liver, and it means stop and seek care.
- Getting sicker despite treatment — worsening shortness of breath and fever during treatment for an aspergillosis or other mould infection can signal a breakthrough by a resistant strain, which needs a rethink of the whole plan.
- Visual changes on voriconazole — flashing lights or blurred vision should be reported. They are usually the harmless, temporary light show described earlier, but they are worth a clinician's eye to be sure.
- A spreading rash, especially with blistering, peeling, or sores in the mouth and eyes, on any antifungal. This can be the start of a severe skin reaction such as Stevens-Johnson syndrome — rare, but documented with itraconazole and voriconazole, and a medical emergency.
- Swelling, light-headedness, or trouble breathing soon after an intravenous dose in hospital — staff need to know immediately.
And a quieter flag: if you are pregnant or might be, the antifungal conversation changes completely. Do not start one on your own — see the myths below for why.
What people get wrong
"One fluconazole tablet clears any fungal infection." A single dose can settle a simple bout of vaginal or oral thrush, and that success creates a myth. But azoles mostly halt fungal growth rather than killing outright, and many infections need a long campaign. Nail fungus runs for months; an infection deep in the body can take weeks to months. One pill is the exception, not the rule.
"Antifungals are gentler than antibiotics." They are not. The azoles in particular can injure the liver, amphotericin can injure the kidneys, and azole drug interactions can turn an unrelated medication dangerous. "Antifungal" does not mean "mild."
"Fluconazole works for every fungus." Several increasingly common organisms shrug it off. Certain Candida species are naturally resistant, and Candida auris — a pathogen that emerged on three continents at once and spreads through hospitals — is frequently resistant to fluconazole and sometimes to almost everything (Lockhart et al., Clinical Infectious Diseases, 2017). One drug is not a master key.
"You should always take fluconazole after a course of antibiotics." Antibiotics can sometimes let thrush flare, but that does not make a routine antifungal chaser a good idea. It is treatment for an infection that has actually appeared, not automatic insurance against one that might.
"Antifungals are safe in pregnancy." Fluconazole, especially at higher or repeated doses, has been linked to birth defects, and the U.S. Food and Drug Administration issued a safety communication on this in 2016. Pregnancy is exactly the situation where you do not self-treat a fungal infection.
"Nail fungus is a four-to-six week treatment." Systemic terbinafine for a toenail typically runs for months, and even after the drug has done its job you have to wait further months for a clean nail to grow out and replace the damaged one. Patience is part of the prescription.
"A positive fungal culture means I need treatment." Not necessarily. Candida quietly lives on the skin and in the gut of perfectly healthy people, so a swab that grows it is not automatically a diagnosis. A positive culture has to be read in the light of how the person actually feels — context decides, not the lab slip alone.